Advertisement

Picture Berlin Partner Voices Peter Seeberger Chemistry Transformation 650x100px
Organisation › Details

Kurma Biofund III

In December 2018 Kurma Partners has completed the first closing of its third Biofund, Kurma Biofund III, with a target for the final closing of €150m. Kurma Biofund III is backed by cornerstone investors including Servier, Bpifrance and Idinvest. Kurma Biofund III will invest in private companies, addressing high unmet medical and patient needs. The previous Biofund, Kurma Biofund II invested in twelve companies, among which four: Step Pharma, Dynacure, ImCheck and Pharvaris, were (co)-created by Kurma under this model. With this new fund, the team will build a portfolio of approximately twelve to fifteen companies, of which four to five will be new companies founded by Kurma Partners. As for its other funds, Kurma associated a mix of strategic investor and long-term LPs to create the conditions for this first close. Servier, Bpifrance and Idinvest are cornerstone investors and will have a seat at the fund Advisory Committee. Other institutional investors and family offices are also part of this first closing. *

 

Period Start 2018-12-14 fund closing 1st
  Group Eurazeo (Group)
  Predecessor Kurma Biofund II (The Orphan Initiative)
Products Industry venture capital
  Industry 2 LIFE SCIENCES
Persons Person Laugel, Thierry (Kurma Life Sciences Partners 201103 Managing Partner at Kurma BioFund before AGF Private Equity)
  Person 2 Droller, Rémi (Kurma 201305 Managing Partner at Kurma Life Sciences Partners)
     
Region Region Paris
  Country France
  City n. a. Paris
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
  Currency EUR
  Annual sales 160,000,000 (fund size, at closing (2020) 2020-04-29)
     
    * Document for »About Section«: Kurma Partners. (12/14/18). "Press Release: Kurma Partners Announces the First Closing of Kurma Biofund III". Paris.
     
   
Record changed: 2024-02-12

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Eurazeo (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Cardiovascular Health in Berlin-Brandenburg 650x300px




» top